AU Patent

AU2005202144B2 — Quinuclidine derivatives and their use as muscarinic M3 receptor ligands

Assigned to Almirall SA · Expires 2007-06-14 · 19y expired

What this patent protects

Patent listed against Tudorza Pressair.

Drugs covered by this patent

Tudorza Pressair (ACLIDINIUM BROMIDE) · Covis

Patent Metadata

Patent number: AU2005202144B2
Jurisdiction: AU
Classification: —
Expires: 2007-06-14
Drug substance claim: No
Drug product claim: No
Assignee: Almirall SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.